AKBA
Akebia Therapeutics, Inc.
0.865$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +1,259.3% | +36.7% | +44.8% | +111.5% | -47.4% | +6.2% | +9.0% | +12.6% | +21.4% | +38.7% | -8.8% | -24.4% | +27.2% | +1.9% | -33.5% | -5.5% | -7.8% | +1.2% | -7.9% | +18.3% | +7.0% | +104.8% | -61.4% | +13.3% | -27.5% | +40.9% | -25.4% | +33.7% | -42.0% | +33.9% | -14.3% | +24.2% | +23.3% | +9.0% | -5.9% | -2.0% | -7.1% | -8.2% | – | |
| – | +7.0% | +79.6% | -27.1% | +34.2% | +16.5% | -10.2% | +17.1% | -1.8% | -89.1% | +306.7% | +20.5% | +1.6% | -73.8% | +176.2% | +530.1% | -82.6% | -11.6% | +29.0% | +51.7% | -69.6% | +99.0% | -1.2% | -40.7% | +105.8% | -108.1% | – | -14.4% | +4.2% | +3.6% | -85.5% | +205.6% | +70.7% | +43.8% | -62.6% | +30.1% | -2.2% | +25.9% | +3.3% | -17.4% | – | |
| – | – | – | – | – | – | -181.7% | – | – | – | -20.6% | +52.5% | -14.9% | +10.8% | +2.1% | -239.0% | – | +0.8% | -40.8% | -97.6% | +7,749.8% | -20.9% | +17.0% | +255.0% | -90.3% | +458.6% | -66.0% | +97.3% | -38.5% | +56.1% | -20.4% | +18.3% | -34.2% | +12.3% | +90.2% | +5.7% | -6.6% | -7.5% | -9.9% | -5.4% | – | |
| – | +7.0% | +79.6% | -27.1% | +34.2% | +16.5% | -10.2% | +17.1% | -1.8% | +23.3% | -5.5% | +4.1% | -13.0% | +7.9% | +1.0% | -35.0% | -11.3% | -19.8% | +8.1% | -8.4% | +8.8% | -27.0% | +48.3% | -40.6% | +7.7% | +13.8% | -38.3% | +2.6% | -34.0% | -26.0% | -1.4% | -21.4% | +11.0% | +38.9% | -17.2% | +12.9% | +32.8% | +82.2% | -44.4% | -5.1% | – | |
| – | +24.3% | -5.8% | +19.3% | -2.3% | +12.1% | +19.3% | +38.9% | -17.2% | +431.8% | -36.5% | +5.5% | -5.0% | +10.9% | -0.7% | -5.5% | +11.9% | -13.6% | +19.0% | +1.2% | +11.0% | -22.5% | +23.0% | -25.1% | -6.0% | -26.7% | -99.3% | +15,992.9% | -16.0% | -96.2% | +2,878.7% | +5.8% | -1.5% | -13.0% | +11.6% | +3.2% | +9.6% | -10.3% | +16.7% | -7.4% | – | |
| – | +9.4% | +66.3% | -23.1% | +29.2% | +16.0% | -7.3% | +19.9% | -4.1% | +75.7% | -17.5% | +4.5% | -10.6% | +40.9% | -22.4% | -25.5% | -1.8% | +31.4% | -28.3% | -3.5% | +10.0% | +4.1% | -2.7% | -17.1% | -17.4% | +6.2% | -29.7% | +5.9% | -22.9% | -2.5% | +24.0% | -1.7% | -18.8% | +13.0% | -10.5% | +6.3% | +16.0% | +20.9% | -15.4% | -1.3% | – | |
| – | – | – | – | – | – | -315.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -247.9% | – | – | – | – | – | -1,187.0% | – | – | – | – | +4.3% | -68.4% | -292.2% | – | – | – | |
| – | -18.3% | +143.0% | +39.8% | +38.5% | +8.4% | +17.9% | +45.1% | +14.0% | -2.4% | -50.0% | -44.2% | -53.0% | +246.5% | +149.6% | +17.0% | -1.5% | +1.9% | +107.4% | +3.3% | +2.5% | 0.0% | -0.4% | -0.5% | -21.5% | -58.6% | -4.6% | +5.2% | -14.1% | +0.6% | +76.2% | -14.0% | +210.0% | +3.2% | +13.0% | -12.0% | -30.5% | +1.7% | -2.8% | -34.5% | – | |
| – | – | – | – | – | – | -290.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -283.7% | – | – | – | – | – | -3,029.2% | – | – | – | – | -96.0% | +367.6% | -1,072.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +32.5% | -0.6% | +16.3% | -387.8% | – | +25.4% | -11.5% | -192.2% | – | +17.8% | -16.3% | -68.9% | -887.9% | – | +1,354.3% | -100.1% | – | – | – | – | – | – | – | +64.1% | -87.5% | -44.4% | – | |
| – | – | – | – | – | – | -290.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -283.7% | – | – | – | – | – | -3,029.2% | – | – | – | – | -96.0% | +118.6% | -2,367.4% | – | – | – | |
| – | – | – | – | – | – | -310.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -192.7% | – | -192.5% | – | – | – | -143.0% | – | -437.9% | – | – | -47.9% | -15.9% | -197.8% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.